People who have undiagnosed cancer often exhibit other symptoms, like unexplained weight loss and frequent fever
Semaglutide, the active ingredient in Ozempic and Wegovy, was patented a decade earlier than tirzepatide, leading to an earlier expiration of its core patents. Semaglutide's patents in China are set to expire in 2026, with some secondary patents extending into the early 2030s
This supports healthy mitochondria, boosts ATP output, and rejuvenates key systems related to stress response, aging, cognition, and metabolic control
Oral formulations on the horizon Both semaglutide and retatrutide are currently administered by injection
From month three onward, the cost increases to $449 per month as patients move to higher dosages